Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
Titel:
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
Auteur:
Ohman, E Magnus Roe, Matthew T Steg, P Gabriel James, Stefan K Povsic, Thomas J White, Jennifer Rockhold, Frank Plotnikov, Alexei Mundl, Hardi Strony, John Sun, Xiang Husted, Steen Tendera, Michal Montalescot, Gilles Bahit, M Cecilia Ardissino, Diego Bueno, Héctor Claeys, Marc J Nicolau, Jose C Cornel, Jan H Goto, Shinya Kiss, Róbert Gábor Güray, Ümit Park, Duk-Woo Bode, Christoph Welsh, Robert C Gibson, C Michael